Beranda › Amiloidosis
Uji klinis Amiloidosis yang merekrut di AS
29 studi untuk Amiloidosis merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Boston, MA11 studi
- New York City, NY10 studi
- Rochester, MN10 studi
- Dallas, TX9 studi
- Philadelphia, PA7 studi
- St. Louis, MO6 studi
- Baltimore, MD6 studi
- Portland, OR6 studi
- Houston, TX6 studi
- Durham, NC6 studi
- Cleveland, OH5 studi
- Chicago, IL5 studi
- San Diego, CA5 studi
- Washington, DC5 studi
- Nashville, TN5 studi
- Jacksonville, FL4 studi
- Charlotte, NC4 studi
- Seattle, WA4 studi
- Detroit, MI4 studi
- Richmond, VA4 studi
- San Francisco, CA4 studi
- Los Angeles, CA4 studi
- Kansas City, KS3 studi
- Edison, NJ3 studi
- Columbus, OH3 studi
- Atlanta, GA3 studi
- Mountain View, CA3 studi
- Aurora, CO3 studi
- Miami, FL3 studi
- Charleston, SC3 studi
- Austin, TX3 studi
- Indianapolis, IN3 studi
- Arlington, VA3 studi
- Salt Lake City, UT3 studi
- Kansas City, MO3 studi
- New Haven, CT3 studi
Berdasarkan negara bagian
- Arizona3 studi
- California8 studi
- Colorado5 studi
- Connecticut4 studi
- Distrik Columbia4 studi
- Florida8 studi
- Georgia3 studi
- Illinois5 studi
- Indiana3 studi
- Kansas3 studi
- Maryland7 studi
- Massachusetts11 studi
- Michigan5 studi
- Minnesota10 studi
- Missouri7 studi
- New Jersey3 studi
- New York10 studi
- North Carolina10 studi
- Ohio6 studi
- Oregon6 studi
- Pennsylvania7 studi
- South Carolina4 studi
- Tennessee7 studi
- Texas11 studi
- Utah3 studi
- Virginia4 studi
- Washington4 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07285044A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT05652335Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Menerima pesertaStudi observasional
Usia 18 hingga 130 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT06465810TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Menerima pesertaFase 3
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07052903TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
Menerima pesertaFase 3
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07223203DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07358078Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program
Menerima pesertaStudi observasional
Semua usia · Wanita · Diperbarui 8 Sep 2026 · NCT05040373ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT04561518Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
Menerima peserta
Usia 65 ke atas · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT05577819Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers
Menerima pesertaStudi observasional
Usia 30 hingga 80 · Semua jenis kelamin · Diperbarui 31 Agu 2026 · NCT05489549Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT05145816Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT06563895Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis
Menerima pesertaFase 4
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 29 Jul 2026 · NCT07695701A Phase 1 Study of 99mTc-p5+14 in Healthy Volunteers and Patients With AL or ATTR Systemic Amyloidosis
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Jul 2026 · NCT05951816[64Cu]FBP8 PET for Early Detection of Intracardiac Thrombus in Amyloid Cardiomyopathy
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Jul 2026 · NCT07560306A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Jul 2026 · NCT07224672A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Jul 2026 · NCT07081646Dietary Reporting In The Amyloidoses
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Jun 2026 · NCT05738005Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid Load
Menerima pesertaFase 1
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 19 Mei 2026 · NCT06974877A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Mei 2026 · NCT06158854Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis
Menerima pesertaFase 2
Usia 40 hingga 90 · Semua jenis kelamin · Diperbarui 13 Apr 2026 · NCT05758493MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Menerima pesertaFase 3
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 27 Mar 2026 · NCT06128629Determining the Association of TTR Stabilizing Therapy With Circulating TTR Amyloid Aggregates Over Time in Patients With ATTR-CM: Longitudinal Biomarker Study
Menerima pesertaStudi observasional
Usia 30 hingga 80 · Semua jenis kelamin · Diperbarui 7 Jan 2026 · NCT07196839Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Des 2025 · NCT04991103A Study Of Myocardial Stiffness In Amyloidosis With Magnetic Resonance Elastography
Menerima pesertaStudi observasional
Usia 20 ke atas · Semua jenis kelamin · Diperbarui 26 Des 2025 · NCT07216469Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.